This attack's damage isn't affected by Resistance.
This attack also does 60 damage to each Benched Pokémon that has any damage counters on it (both yours and your opponent's). (Don't apply Weakness and Resistance for Benched Pokémon.)
Release year for Sword & Shield is 2020. Series classification for this set is Sword & Shield.
Set size is 216 cards, which categorizes Sword & Shield as large. As of 2026, the set is 6 years old and sits in a modern-era collecting window.
In the Sword & Shield checklist, Rhyperior occupies position #99 as a Rare Holo card.
In 2020, Sword & Shield introduced this print of Rhyperior. Card flavor text reads: "It relies on its carapace to deflect incoming attacks and throw its enemy off balance.
As soon as that happens, it drives its drill into the foe." Its card type is Pokémon. The rarity label is Rare Holo.
Printed HP is 190. Energy typing is Fighting.
This gives collectors a clear identity footprint for the print. Rhyperior evolves from Rhydon.
Rhyperior from Sword & Shield is currently trading around $0.29. Week-over-week change is limited (0.0%), indicating short-term stability.
Relative to the last 30 days, value is near baseline at $0.29. The 90-day window shows a floor near $0.26 and a peak around $0.32 (21% total spread), which maps to moderate-volatility movement.
This version is categorized as Rare Holo.
Rhyperior sits within a broader pool of Rhyperior variants that can be compared by set, rarity, and price. This comparison sample includes 6 alternatives across 5 sets.
Observed alternatives run from $0.11 to $4.02 (3555% spread). The current card sits -70% versus the sampled alternative average of $0.96.
Notable alternatives include Rhyperior #76 (Primal Clash) at $0.41, Rhyperior #77 (Primal Clash) at $4.02, Rhyperior #62 (XY) at $0.64, and Rhyperior #91 (Lost Origin) at $0.11.
Current valuation lens: We observe a 0.0% shift this week, which points toward price consolidation rather than immediate volatility. Observed 90-day bounds of $0.26 and $0.32 create a 21% band, matching a moderate-volatility profile.
Current value remains close to its 30-day mean ($0.29). Condition sensitivity is substantial: PSA 10 carries a +18693% premium over raw value.
PSA 10 is currently around $54.50.
